High-energy phosphate metabolism in the exercising muscle of patients with peripheral arterial disease

Vasa - Journal of Vascular Diseases

Volumn 37, Issue 3, 2008, Pages 199-210

  Schocke, Michael F H ^a   Esterhammer, R ^a   Greiner, A ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

High energy phosphate metabolism; Mitochondrial capacity; Peripheral arterial disease; Phosphorus 31 magnetic resonance spectroscopy

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; CYTOCHROME C OXIDASE; PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; PHOSPHORUS;

ANAEROBIC GLYCOLYSIS; ARTERY BYPASS; ARTERY DISEASE; ATHEROSCLEROSIS; ENZYME ACTIVATION; EXERCISE TOLERANCE; HEALTH CARE COST; HUMAN; INTERMITTENT CLAUDICATION; MUSCLE DISEASE; MUSCLE EXERCISE; MUSCLE METABOLISM; MUSCLE MITOCHONDRION; MUSCLE PERFUSION; OXYGEN SUPPLY; PHOSPHATE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; QUALITY OF LIFE; REVIEW; ENERGY METABOLISM; EXERCISE; EXERCISE TEST; MAGNETIC RESONANCE ANGIOGRAPHY; METABOLISM; MUSCLE CONTRACTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN CONSUMPTION; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; SKELETAL MUSCLE; TIME;

ADENOSINE TRIPHOSPHATE; ENERGY METABOLISM; EXERCISE; EXERCISE TEST; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE SPECTROSCOPY; MITOCHONDRIA, MUSCLE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PERIPHERAL VASCULAR DISEASES; PHOSPHOCREATINE; PHOSPHORUS ISOTOPES; TIME FACTORS;

EID: 85047684680     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.37.3.199     Document Type: Review

References (87)

1. Anwaruddin S, Januzzi JLJ, Baggish AL, Lewandrowski EL, Lewandrowski KB. Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 2005; 123: 140-5.
2. Askew CD,Green S, Walker PJ, Kerr GK, Green AA, Williams AD, Febbraio MA. Skeletal muscle phenotype is associated with exercise tolerance in patients with peripheral arterial disease. J Vasc Surg 2005; 41: 802-7.
3. 31p-magnetic resonance spectroscopy during an exhaustive incremental exercise test in children. Eur J Appl Physiol 2006; 98: 556-65.
4. Bauer TA, Brass EP, Hiatt WR. Impaired muscle oxygen use at onset of exercise in peripheral arterial disease. J Vasc Surg 2004; 40: 488-93.
5. Bauer TA, Brass EP, Barstow TJ, Hiatt WR. Skeletal muscle StO(2) kinetics are slowed during low work rate calf exercise in peripheral arterial disease. Eur J Appl Physiol 2007; 100: 143-51.
6. Baumgartner I, Thoeny HC, Kummer O, Roefke C, Skjelsvik C, Boesch C, Kreis R. Leg ischemia: assessment with MR angiography and spectroscopy. Radiology 2005; 234: 833-41.
7. Binzoni T. Human skeletal muscle energy metabolism: when a physiological model promotes the search for new technologies. Eur J Appl Physiol 2003; 90: 260-9.
8. Boesch C. Musculoskeletal spectroscopy. J Magn Reson Imaging 2007; 25: 321-38.
9. 31p MRS studies of exercising human muscle at high temporal resolution. Magn Reson Med 1999; 41: 1145-51.
10. Bottomley PA. Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? Radiology 1989; 170: 1-15.
11. Canfield P, Marechal G. Equilibrium of nucleotides in frog sartorius muscle during an isometric tetanus at 20 degrees C. J Physiol 1973; 232: 453-66.
12. Carlier PG, Bertoldi D, Baligand C, Wary C, Fromes Y. Muscle blood flow and oxygenation measured by NMR imaging and spectroscopy. NMR Biomed 2006; 19: 954-67.
13. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510-5.
14. Dash RK, Bell BM, Kushmerick MJ, Vicini P. Estimating in vitro mitochondrial oxygen consumption during muscle contraction and recovery: a novel approach that accounts for diffusion. Ann Biomed Eng 2005; 33: 343-55.
15. Delp MD, Laughlin MH. Regulation of skeletal muscle perfusion during exercise. Acta Physiol Scand 1998; 162: 411-9.
16. Di Prampero PE. Energetics of muscular exercise. Rev Physiol Biochem Pharmacol 1981; 89: 143-222.
17. Duteil S, Bourrilhon C, Raynaud JS, Wary C, Richardson RS, Leroy-Willig A, Jouanin JC, Guezennec CY, Carlier PG. Metabolic and vascular support for the role of myoglobin in humans: a multiparametric NMR study. Am J Physiol Regul Integr Comp Physiol 2004; 287: R1441-9.
18. Duteil S, Bourrilhon C, Raynaud JS, Wary C, Richardson RS, Leroy-Willig A, Jouanin JC, Guezennec CY, Carlier PG. Metabolic and vascular support for the role of myoglobin in humans: a multiparametric NMR study. Am J Physiol Regul Integr Comp Physiol 2004; 287: R1441-9.
19. Esterhammer R, Schocke M, Gorny O, Posch L, Messner H, Jaschke W, Fraedrich G, Greiner A. Phosphocreatine kinetics in the calf muscle of patients with bilateral symptomatic peripheral arterial disease during exhaustive incremental exercise. Mol Imaging Biol 2008; 10: 30-9.
20. Falkensammer J, Stojakovic T, Huber K, Hammerer-Lercher A, Gruber I, Scharnagl H, Fraedrich G, Santner W, Schocke M, Greiner A. Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia. Clin Chem Lab Med 2007; 45: 535-40.
21. Francescato MP, Cettolo V, Di Prampero PE. Relationships between mechanical power, O(2) consumption, O(2) deficit and high-energy phosphates during calf exercise in humans. Pflugers Arch 2003; 445: 622-8.
22. Gladden LB. Lactate metabolism: a new paradigm for the third millennium. J Physiol 2004; 558: 5-30.
23. Grassi B. Oxygen uptake kinetics: old and recent lessons from experiments on isolated muscle in situ. Eur J Appl Physiol 2003; 90: 242-9.
24. Grassi B. Delayed metabolic activation of oxidative phosphorylation in skeletal muscle at exercise onset. Med Sci Sports Exerc 2005; 37: 1567-73.
25. Greiner A, Esterhammer R, Pilav S, Arnold W, Santner W, Neuhauser B, Fraedrich G, Jaschke WR, Schocke MFH. High-energy phosphate metabolism in the calf muscle during moderate isotonic exercise under different degrees of cuff compression: a phosphorus 31 magnetic resonance spectroscopy study. J Vasc Surg 2005;42:259-67.
26. Greiner A, Esterhammer R, Messner H, Biebl M, Muhlthaler H, Fraedrich G, Jaschke WR, Schocke MFH. High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy. J Vasc Surg 2006; 43: 978-86.
27. Greiner A, Esterhammer R, Bammer D, Messner H, Kremser C, Jaschke W, Fraedrich G, Schocke M. High-energy phosphate metabolism in the calf muscle of healthy humans during incremental calf exercise with and without moderate cuff stenosis. Eur J Appl Physiol 2007; 99: 519-31.
28. 31p-magnetic resonance spectroscopy. Eur J Vasc Surg 1990; 4: 637-42.
29. Harper AJ, Ferreira LF, Lutjemeier BJ, Townsend DK, Barstow TJ. Human femoral artery and estimated muscle capillary blood flow kinetics following the onset of exercise. Exp Physiol 2006; 91: 661-71.
30. 31p-MRS assessment of O2 supply and demand limitations. J Appl Physiol 2004; 97: 1077-81.
31. He Y, Jiang Y, Wang J, Fan L, Li X, Hu FB. Prevalence of peripheral arterial disease and its association with smoking in a population-based study in Beijing, China. J Vasc Surg 2006; 44: 333-8.
32. Heidrich H, Hermann GM. Concomitant neurological and orthopaedic diseases in the presence of peripheral arterial disease: a prospective study. Vasa 2006; 35: 101-5.
33. 31p-MRS study. Med Sci Sports Exerc 2005; 37: 846-52.
34. Hug F, Grelot L, Le Fur Y, Cozzone PJ, Bendahan D. Recovery kinetics throughout successive bouts of various exercises in elite cyclists. Med Sci Sports Exerc 2006; 38: 2151-8.
35. Iannetti GD, Wise RG. BOLD functional MRI in disease and pharmacological studies: room for improvement? Magn Reson Imaging 2007; 25: 978-88.
36. Iotti S, Gottardi G, Clementi V, Barbiroli B. The mono-exponential pattern of phosphocreatine recovery after muscle exercise is a particular case of a more complex behaviour. Biochim Biophys Acta 2004; 1608: 131-9.
37. Isbell DC, Berr SS, Toledano AY, Epstein FH, Meyer CH, Rogers WJ, Harthun NL, Hagspiel KD, Weltman A, Kramer CM. Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease. J Am Coll Cardiol 2006; 47: 2289-95.
38. Izquierdo-Porrera AM, Gardner AW, Bradham DD, Montgomery PS, Sorkin JD, Powell CC, Katzel LI. Relationship between objective measures of peripheral arterial disease severity to self-reported quality of life in older adults with intermittent claudication. J Vasc Surg 2005; 41: 625-30.
39. 31p-MRS characterization of sprint and endurance trained athletes. Int J Sports Med 2003; 24: 183-9.
40. Keller U, Oberhansli R, Huber P, Widmer LK, Aue WP, Hassink RI, Muller S, Seelig J. Phosphocreatine content and intracellular pH of calf muscle measured by phosphorus NMR spectroscopy in occlusive arterial disease of the legs. Eur J Clin Invest 1985; 15: 382-8.
41. 31p magnetic resonance spectroscopy. Clin Sci (Lond) 1995; 89: 581-90.
42. 31p magnetic resonance spectroscopy and near infrared spectroscopy study in vivo. J Vasc Surg 2001; 34: 1103-10.
43. 31p MRS: a quantitative review. NMR Biomed 2007; 20: 555-65.
44. Khan NA, Rahim SA, Anand SS, Simel DL, Panju A. Does the clinical examination predict lower extremity peripheral arterial disease? JAMA 2006; 295: 536-46.
45. Koulmann N, Bigard A. Interaction between signalling pathways involved in skeletal muscle responses to endurance exercise. Pflugers Arch 2006; 452: 125-39.
46. Kreis R, Bruegger K, Skjelsvik C, Zwicky S, Ith M, Jung B, Baumgartner I, Boesch C. Quantitative (1)H magnetic resonance spectroscopy of myoglobin de- and reoxygenation in skeletal muscle: reproducibility and effects of location and disease. Magn Reson Med 2001; 46: 240-8.
47. Lanza IR, Wigmore DM, Befroy DE, Kent-Braun JA. In vivo ATP production during free-flow and ischaemic muscle contractions in humans. J Physiol 2006; 577: 353-67.
48. Lott ME, Hogeman CS, Vickery L, Kunselman AR, Sinoway LI, MacLean DA. Effects of dynamic exercise on mean blood velocity and muscle interstitial metabolite responses in humans. Am J Physiol Heart Circ Physiol 2001; 281: H1734-41.
49. Mahler M. First-order kinetics of muscle oxygen consumption, and an equivalent proportionality between QO2 and phosphorylcreatine level. Implications for the control of respiration. J Gen Physiol 1985; 86: 135-65.
50. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001; 286: 1599-606.
51. McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, Chan C, Pearce WH, Schneider JR, Ferrucci L, Celic L, Taylor LM, Vonesh E, Martin GJ, Clark E. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 2004; 292: 453-61.
52. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18: 185-92.
53. Meyer RA. A linear model of muscle respiration explains monoexponential phosphocreatine changes. Am J Physiol 1988; 254: C548-53.
54. Meyerspeer M, Kemp GJ, Mlynarik V, Krssak M, Szendroedi J, Nowotny P, Roden M, Moser E. Direct noninvasive quantification of lactate and high energy phosphates simultaneously in exercising human skeletal muscle by localized magnetic resonance spectroscopy. Magn Reson Med 2007; 57: 654-60.
55. Moyes CD, Hood DA. Origins and consequences of mitochondrial variation in vertebrate muscle. Annu Rev Physiol 2003; 65: 177-201.
56. Murrant CL, Sarelius IH. Coupling of muscle metabolism and muscle blood flow in capillary units during contraction. Acta Physiol Scand 2000; 168: 531-41.
57. Nevill AM, Jones DA, McIntyre D, Bogdanis GC, Nevill ME. A model for phosphocreatine resynthesis. J Appl Physiol 1997; 82: 329-35.
58. Peacock F, Morris DL, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, Januzzi JL, Jesse RL, Kaski JC, Kontos MC, Lefevre G, Mutrie D, Sinha MK, Uettwiller-Geiger D, Pollack CV. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006; 152: 253-62.
59. Petersen ET, Zimine I, Ho YL, Golay X. Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques. Br J Radiol 2006; 79: 688-701.
60. Pipinos II, Shepard AD, Anagnostopoulos PV, Katsamouris A, Boska MD. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle. J Vasc Surg 2000; 31: 944-52.
61. Pipinos II, Sharov VG, Shepard AD, Anagnostopoulos PV, Katsamouris A, Todor A, Filis KA, Sabbah HN. Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease. J Vasc Surg 2003; 38: 827-32.
62. Pipinos II, Judge AR, Zhu Z, Selsby JT, Swanson SA, Johanning JM, Baxter BT, Lynch TG, Dodd SL. Mitochondrial defects and oxidative damage in patients with peripheral arterial disease. Free Radic Biol Med 2006; 41: 262-9.
63. Di Prampero PE, Francescato MP, Cettolo V. Energetics of muscular exercise at work onset: the steady-state approach. Pflugers Arch 2003; 445: 741-6.
64. Refaai MA, Wright RW, Parvin CA, Gronowski AM, Scott MG, Eby CS. Ischemia-modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery. Clin Chim Acta 2006; 366: 264-8.
65. Richardson RS, Duteil S, Wary C, Wray DW, Hoff J, Carlier PG. Human skeletal muscle intracellular oxygenation: the impact of ambient oxygen availability. J Physiol 2006; 571: 415-24.
66. Robergs RA, Ghiasvand F, Parker D. Biochemistry of exercise-induced metabolic acidosis. Am J Physiol Regul Integr Comp Physiol 2004; 287: R502-16.
67. 31p MRS). Magn Reson Imaging 2004; 22: 109-15.
68. Schocke MFH, Esterhammer R, Arnold W, Kammerlander C, Burtscher M, Fraedrich G, Jaschke WR, Greiner A. High-energy phosphate metabolism during two bouts of progressive calf exercise in humans measured by phosphorus-31 magnetic resonance spectroscopy. Eur J Appl Physiol 2005; 93: 469-79.
69. Schocke MFH, Esterhammer R, Ostermann S, Santner W, Gorny O, Fraedrich G, Jaschke WR, Greiner A. High-energy phosphate metabolism during calf ergometry in patients with isolated aorto-iliac artery stenoses. Invest Radiol 2006; 41: 874-82.
70. Schunk K, Romaneehsen B, Mildenberger P, Kersjes W, Schadmand-Fischer S, Thelen M. Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease. Correlation with clinical and angiographic findings and comparison with healthy volunteers. Invest Radiol 1997; 32: 651-9.
71. Schunk K, Romaneehsen B, Rieker O, Duber C, Kersjes W, Schadmand-Fischer S, Schmiedt W, Thelen M. Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease: effects of vascular therapy on spectroscopic results. Invest Radiol 1998; 33: 329-35.
72. Schunk K, Losch O, Kreitner KF, Kersjes W, Schadmand-Fischer S, Thelen M. Contributions of dynamic phosphorus-31 magnetic resonance spectroscopy to the analysis of muscle fiber distribution. Invest Radiol 1999; 34: 348-56.
73. Stoffers HE, Rinkens PE, Kester AD, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol 1996; 25: 282-90.
74. Street D, Bangsbo J, Juel C. Interstitial pH in human skeletal muscle during and after dynamic graded exercise. J Physiol 2001; 537: 993-8.
75. 31p nuclear magnetic resonance study. Mol Biol Med 1983; 1: 77-94.
76. 31p magnetic resonance spectroscopy: a phase II open study. Vasc Med 1996; 1: 241-5.
77. Taylor DJ. Clinical utility of muscle MR spectroscopy. Semin Musculoskelet Radiol 2000; 4: 481-502.
78. Troxler M, Thompson D, Homer-Vanniasinkam S. Ischaemic skeletal muscle increases serum ischaemia modified albumin. Eur J Vasc Endovasc Surg 2006; 31: 164-9.
79. Wahl DG, Simon JP, Robin B, Walker P, Jouanny P, Escanye JM, Paille F, Schmidt C, Brunotte F, Robert J. Phosphorus magnetic resonance spectroscopy: a non-invasive technique for the study of occlusive arterial leg disease and peripheral vasodilator therapy. Angiology 1994; 45: 367-76.
80. Wang JC, Criqui MH, Denenberg JO, McDermott MM, Golomb BA, Fronek A. Exertional leg pain in patients with and without peripheral arterial disease. Circulation 2005; 112: 3501-8.
81. Williams DM, Fencil L, Chenevert TL. Peripheral arterial occlusive disease: P-31 MR spectroscopy of calf muscle. Radiology 1990; 175: 381-5.
82. Yoshida T, Watari H. Effect of circulatory occlusion on human muscle metabolism during exercise and recovery. Eur J Appl Physiol Occup Physiol 1997; 75: 200-5.
83. Yoshida T. The rate of phosphocreatine hydrolysis and resynthesis in exercising muscle in humans using 31p-MRS. J Physiol Anthropol Appl Human Sci 2002; 21: 247-55.
84. 31p nuclear magnetic resonance spectroscopy: noninvasive biochemical analysis of the ischemic extremity. J Vasc Surg 1986; 3: 411-20.
85. Zierath JR, Hawley JA. Skeletal muscle fiber type: influence on contractile and metabolic properties. PLoS Biol 2004; 2: e348.
86. Zwierska I, Walker RD, Choksy SA, Male JS, Pockley AG, Saxton JM. Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial. J Vasc Surg 2005; 42: 1122-30.
87. Zwierska I, Walker RD, Choksy SA, Male JS, Pockley AG, Saxton JM. Relative tolerance to upper-and lower-limb aerobic exercise in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg 2006; 31: 157-63.